ArticleNPJ breast cancer2024

Alternative dosing regimen of exemestane in a randomized presurgical trial: the role of obesity in biomarker modulation.

Harriet Johansson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.